Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LI-FRAUMENI SYNDROME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 236 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marsh, A; Spurdle, AB; Turner, BC; Fereday, S; Thorne, H; Pupo, GM; Mann, GJ; Hopper, JL; Sambrook, JF; Chenevix-Trench, G
      The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

      BREAST CANCER RESEARCH
    2. Rotterud, R; Berner, A; Holm, R; Skovlund, E; Fossa, SD
      p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

      BJU INTERNATIONAL
    3. Prime, SS; Thakker, NS; Pring, M; Guest, PG; Paterson, IC
      A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma

      ORAL ONCOLOGY
    4. Geske, FJ; Lieberman, R; Strange, R; Gerschenson, LE
      Early stages of p53-induced apoptosis are reversible

      CELL DEATH AND DIFFERENTIATION
    5. Chang, S; Khoo, C; DePinho, RA
      Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse

      SEMINARS IN CANCER BIOLOGY
    6. Parshad, R; Sanford, KK
      Radiation-induced chromatid breaks and deficient DNA repair in cancer predisposition

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    7. Kusano, M; Kakiuchi, H; Mihara, M; Itoh, F; Adachi, Y; Ohara, M; Hosokawa, M; Imai, K
      Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer

      TUMOR BIOLOGY
    8. Bean, LJH; Stark, GR
      Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV

      ONCOGENE
    9. McKay, BC; Becerril, C; Ljungman, M
      P53 plays a protective role against UV- and cisplatin-induced apoptosis intranscription-coupled repair proficient fibroblasts

      ONCOGENE
    10. Birch, JM; Alston, RD; McNally, RJQ; Evans, DGR; Kelsey, AM; Harris, M; Eden, OB; Varley, JM
      Relative frequency and morphology of cancers in carriers of germline TP53 mutations

      ONCOGENE
    11. Malkin, D; Chilton-MacNeill, S; Meister, LA; Sexsmith, E; Diller, L; Garcea, RL
      Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome

      ONCOGENE
    12. Varley, JM; Attwooll, C; White, G; McGown, G; Thorncroft, M; Kelsey, AM; Greaves, M; Boyle, J; Birch, JM
      Characterization of germline TP53 splicing mutations and their genetic andfunctional analysis

      ONCOGENE
    13. Hanawalt, PC
      Controlling the efficiency of excision repair

      MUTATION RESEARCH-DNA REPAIR
    14. Hemminki, K; Li, XJ
      A population-based study of familial soft tissue tumors

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    15. Mirzayans, R; Paterson, MC
      Correction of radioresistant DNA synthesis in ataxia telangiectasia fibroblasts by prostaglandin E-2 treatment

      ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    16. Stewart, ZA; Pietenpol, JA
      p53 signaling and cell cycle checkpoints

      CHEMICAL RESEARCH IN TOXICOLOGY
    17. Moppett, J; Oakhill, A; Duncan, AW
      Second malignancies in children: the usual suspects? (vol 37, pg 95, 2001)

      EUROPEAN JOURNAL OF RADIOLOGY
    18. Moppett, J; Oakhill, A; Duncan, AW
      Second malignancies in children: the usual suspects?

      EUROPEAN JOURNAL OF RADIOLOGY
    19. Cadwell, C; Zambetti, GP
      The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

      GENE
    20. Kimura, K; Shinmura, K; Hasegawa, T; Beppu, Y; Yokoyama, R; Yokota, J
      Germline p53 mutation in a patient with multiple primary cancers

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    21. Bishop, AJR; Schiestl, RH
      Homologous recombination as a mechanism of carcinogenesis

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    22. Robles, AI; Harris, CC
      p53-mediated apoptosis and genomic instability diseases

      ACTA ONCOLOGICA
    23. Tong, WM; Hande, MP; Lansdorp, PM; Wang, ZQ
      DNA strand break-sensing molecule poly(ADP-ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression

      MOLECULAR AND CELLULAR BIOLOGY
    24. Portwine, C; Chilton-MacNeill, S; Brown, C; Sexsmith, E; McLaughlin, J; Malkin, D
      Absence of germline and somatic p53 alterations in children with sporadic brain tumors

      JOURNAL OF NEURO-ONCOLOGY
    25. Malkin, D
      The role of p53 in human cancer

      JOURNAL OF NEURO-ONCOLOGY
    26. Frosina, G
      Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes

      CARCINOGENESIS
    27. Torino, JL; Burger, MS; Reznikoff, CA; Swaminathan, S
      Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder

      CARCINOGENESIS
    28. Ribeiro, RC; Sandrini, F; Figueiredo, B; Zambetti, GP; Michalkiewicz, E; Lafferty, AR; DeLacerda, L; Rabin, M; Cadwell, C; Sampaio, G; Cat, I; Stratakis, CA; Sandrini, R
      A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    29. Davison, TS; Nie, X; Ma, WL; Lin, YP; Kay, C; Benchimol, S; Arrowsmith, CH
      Structure and functionality of a designed p53 dimer

      JOURNAL OF MOLECULAR BIOLOGY
    30. Chompret, A; Abel, A; Stoppa-Lyonnet, D; Brugieres, L; Pages, S; Feunteun, J; Bonaiti-Pellie, C
      Sensitivity and predictive value of criteria for p53 germline mutation screening

      JOURNAL OF MEDICAL GENETICS
    31. Limacher, JM; Frebourg, T; Natarajan-Ame, S; Bergerat, JP
      Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome

      INTERNATIONAL JOURNAL OF CANCER
    32. Huschtscha, LI; Neumann, AA; Noble, JR; Reddel, RR
      Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16(INK4A) expression

      EXPERIMENTAL CELL RESEARCH
    33. Robson, M; Boyd, J; Borgen, PI; Cody, HS
      Hereditary breast cancer - In brief

      CURRENT PROBLEMS IN SURGERY
    34. Frebourg, T; Ebel, A; Bonaiti-Pellie, C; Brugieres, L; Berthet, P; Bressac-De Paillerets, B; Chevrier, A; Chompret, A; Cohen-Haguenauer, O; Delattre, O; Feingold, J; Feunteun, J; Frappaz, D; Fricker, JP; Gesta, P; Jonveaux, P; Kalifa, C; Lasset, C; Leheup, B; Limacher, JM; Longy, M; Nogues, C; Oppenheim, D; Sommelet, D; Soubrier, F; Stoll, C; Stoppa-Lyonnet, D; Tristant, H
      Li-Fraumeni syndrome: update, new data and guidelines for clinical management

      BULLETIN DU CANCER
    35. Allinen, M; Huusko, P; Mantyniemi, S; Launonen, V; Winqvist, R
      Mutation analysis of the CHK2 gene in families with hereditary breast cancer

      BRITISH JOURNAL OF CANCER
    36. Boyle, JM; Spreadborough, A; Greaves, MJ; Birch, JM; Varley, JM; Scott, D
      The relationship between radiation-induced G(1) arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations

      BRITISH JOURNAL OF CANCER
    37. Rapakko, K; Allinen, M; Syrjakoski, K; Vahteristo, P; Huusko, P; Vahakangas, K; Eerola, H; Kainu, T; Kallioniemi, OP; Nevanlinna, H; Winqvist, R
      Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

      BRITISH JOURNAL OF CANCER
    38. Tonin, PN
      Genes implicated in hereditary breast cancer syndromes

      SEMINARS IN SURGICAL ONCOLOGY
    39. Wai, HPS; Yau, TK; Sze, WM; Yeung, MW; Lee, AWM
      Quadruple primary neoplasms in a 27-year-old woman

      HOSPITAL MEDICINE
    40. Allio, T; Donner, EM; Preston, RJ
      A comparison of the roles of p53 mutation and AraC inhibition in the enhancement of bleomycin-induced chromatid aberrations in mouse and human cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    41. Grimberg, A
      p53 and IGFBP-3: Apoptosis and cancer protection

      MOLECULAR GENETICS AND METABOLISM
    42. Grzybowska, E; Zientek, H; Jasinska, A; Rusin, M; Kozlowski, P; Sobczak, K; Sikorska, A; Kwiatkowska, E; Gorniak , L; Kalinowska, E; Utracka-Hutka, B; Wloch, J; Chmielik, E; Krzyzosiak, WJ
      High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

      HUMAN MUTATION
    43. McKay, BC; Chen, F; Perumalswami, CR; Zhang, FF; Ljungman, M
      The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis

      MOLECULAR BIOLOGY OF THE CELL
    44. Klein, MA; Ruedi, D; Nozaki, M; Dell, EW; Diserens, AC; Seelentag, W; Janzer, RC; Aguzzi, A; Hegi, ME
      Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant

      ONCOGENE
    45. Verselis, SJ; Rheinwald, JG; Fraumeni, JF; Li, FP
      Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

      ONCOGENE
    46. Nutting, C; Camplejohn, RS; Gilchrist, R; Tait, D; Blake, P; Knee, G; Yao, WQ; Ross, G; Fisher, C; Eeles, R
      A patient with 17 primary tumours and a germ line mutation in TP53: Tumourinduction by adjuvant therapy?

      CLINICAL ONCOLOGY
    47. Oberlin, O; Brugieres, L; Patte, C; Kalifa, C; Vassal, G; Valteau-Couanet, D; Hartmann, O
      Recent progress in pediatric oncology.

      ARCHIVES DE PEDIATRIE
    48. Kimura, K; Shinmura, K; Yoshimura, K; Shimizu, K; Katai, H; Beppu, Y; Moriya, H; Yokota, J
      Absence of germline CHK2 mutations in familial gastric cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    49. Kane, AB
      Oncogenes and tumor suppressor genes in the carcinogenicity of fibers and particles

      INHALATION TOXICOLOGY
    50. Atz, J; Wagner, P; Roemer, K
      Function, oligomerization, and conformation of tumor-associated p53 proteins with mutated C-terminus

      JOURNAL OF CELLULAR BIOCHEMISTRY
    51. Dahm-Daphi, J
      p53: Biology and role for cellular radiosensitivity

      STRAHLENTHERAPIE UND ONKOLOGIE
    52. Tachibana, I; Smith, JS; Sato, K; Hosek, SM; Kimmel, DW; Jenkins, RB
      Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma

      AMERICAN JOURNAL OF MEDICAL GENETICS
    53. Taylor, MD; Mainprize, TG; Rutka, JT
      Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: A review

      NEUROSURGERY
    54. Ribeiro, RC; Michalkiewicz, EL; Figueiredo, BC; DeLacerda, L; Sandrini, F; Pianovsky, MD; Sampaio, G; Sandrini, R
      Adrenocortical tumors in children

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    55. Schultz, LB; Chehab, NH; Malikzay, A; DiTullio, RA; Stavridi, ES; Halazonetis, TD
      The DNA damage checkpoint and human cancer

      COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
    56. Enns, L; Murray, D; Mirzayans, R
      Lack of correlation between DNA strand breakage and p53 protein levels in human fibroblast strains exposed to ultraviolet light

      PHOTOCHEMISTRY AND PHOTOBIOLOGY
    57. Scherer, SJ; Maier, SM; Seifert, M; Hanselmann, RG; Zang, KD; Muller-Hermelink, HK; Angel, P; Welter, C; Schartl, M
      p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV

      JOURNAL OF BIOLOGICAL CHEMISTRY
    58. Zhu, QZ; Wani, MA; El-mahdy, M; Wani, AA
      Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand

      JOURNAL OF BIOLOGICAL CHEMISTRY
    59. Muto, M; Hitomi, Y; Ohtsu, A; Ebihara, S; Yoshida, S; Esumi, H
      Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients

      GUT
    60. Sukata, T; Ozaki, K; Uwagawa, S; Seki, T; Wanibuchi, H; Yamamoto, S; Okuno, Y; Fukushima, S
      Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice

      CANCER RESEARCH
    61. Lynch, HT; McComb, RD; Osborn, NK; Wolpert, PA; Lynch, JF; Wszolek, ZK; Sidransky, D; Steg, RE
      Predominance of brain tumors in an extended Li-Fraumeni (SBLA) kindred, including a case of Sturge-Weber syndrome

      CANCER
    62. Burt, EC; James, LA; Greaves, MJ; Birch, JM; Boyle, JM; Varley, JM
      Genomic alterations associated with loss of heterozygosity for TP53 in Li -Fraumeni syndrome fibroblasts

      BRITISH JOURNAL OF CANCER
    63. Camplejohn, RS; Sodha, N; Gilchrist, R; Lomax, ME; Duddy, PM; Miner, C; Alarcon-Gonzalez, P; Barnes, DM; Eeles, RA
      The value of rapid functional assays of germline p53 status in LFS and LFLfamilies

      BRITISH JOURNAL OF CANCER
    64. Chompret, A; Brugieres, L; Ronsin, M; Gardes, M; Dessarps-Freichey, F; Abel, A; Hua, D; Ligot, L; Dondon, MG; Bressac-de Paillerets, B; Frebourg, T; Lemerle, J; Bonaiti-Pellie, C; Feunteun, J
      p53 germline mutations in childhood cancers and cancer risk for carrier individuals

      BRITISH JOURNAL OF CANCER
    65. Pappo, AS; Parham, DM; Rao, BN; Lobe, TE
      Soft tissue sarcomas in children

      SEMINARS IN SURGICAL ONCOLOGY
    66. Roemer, K
      Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators

      BIOLOGICAL CHEMISTRY
    67. Janus, F; Albrechtsen, N; Dornreiter, I; Wiesmuller, L; Grosse, F; Deppert, W
      The dual role model for p53 in maintaining genomic integrity

      CELLULAR AND MOLECULAR LIFE SCIENCES
    68. Hasebe, T; Imoto, S; Sasaki, S; Tsubono, Y; Mukai, K
      Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: Proposal fibroadenoma, cellular variant

      PATHOLOGY INTERNATIONAL
    69. Kruk, PA; Bohr, VA
      Telomeric length in individuals and cell lines with altered p53 status

      RADIATION ONCOLOGY INVESTIGATIONS
    70. Hung, J; Mims, B; Lozano, G; Strong, L; Harvey, C; Chen, TTY; Stastny, V; Tomlinson, G
      TP53 mutation and haplotype analysis of two large African American families

      HUMAN MUTATION
    71. Van Orsouw, NJ; Vijg, J
      Design and application of 2-D DGGE-based gene mutational scanning tests

      GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING
    72. Scott, D; Barber, JBP; Spreadborough, AR; Burrill, W; Roberts, SA
      Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    73. Albrechtsen, N; Dornreiter, I; Grosse, F; Kim, E; Wiesmuller, L; Deppert, W
      Maintenance of genomic integrity by p53: complementary roles for activatedand non-activated p53

      ONCOGENE
    74. Quesnel, S; Verselis, S; Portwine, C; Garber, J; White, M; Feunteun, J; Malkin, D; Li, FP
      p53 compound heterozygosity in a severely affected child with Li-Fraumeni Syndrome

      ONCOGENE
    75. Daly, M
      NCCN practice guidelines: Genetics/familial high-risk cancer screening

      ONCOLOGY-NEW YORK
    76. Nichols, KE; Levitz, S; Shannon, KE; Wahrer, DCR; Bell, DW; Chang, G; Hegde, S; Neuberg, D; Shafman, T; Tarbell, NJ; Mauch, P; Ishioka, C; Haber, DA; Diller, L
      Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease

      JOURNAL OF CLINICAL ONCOLOGY
    77. Li, FP
      Cancer control in susceptible groups: Opportunities and challenges

      JOURNAL OF CLINICAL ONCOLOGY
    78. Sugano, K; Taniguchi, T; Saeki, M; Tsunematsu, Y; Tomaru, U; Shimoda, T
      Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastriccancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    79. Potzsch, C; Schaefer, HE; Lubbert, M
      Familial and metachronous malignant lymphoma: Absence of constitutional p53 mutations

      AMERICAN JOURNAL OF HEMATOLOGY
    80. Stone, JG; Eeles, RA; Sodha, N; Murday, V; Sheriden, E; Houlston, RS
      Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10

      CANCER LETTERS
    81. Auer, H; Warncke, K; Nowak, D; Koops, F; Jaeger, U; Kurzbauer, R; Ruediger, HW
      Variations of p53 in cultured fibroblasts of patients with lung cancer whohave a presumed genetic predisposition

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    82. McKay, BC; Ljungman, M; Rainbow, AJ
      Potential roles for p53 in nucleotide excision repair

      CARCINOGENESIS
    83. Mirzayans, R; Bashir, S; Murray, D; Paterson, MC
      Inverse correlation between p53 protein levels and DNA repair efficiency in human fibroblast strains treated with 4-nitroquinoline 1-oxide: evidence that lesions other than DNA strand breaks trigger the p53 response

      CARCINOGENESIS
    84. Shackelford, RE; Kaufmann, WK; Paules, RS
      Cell cycle control, checkpoint mechanisms, and genotoxic stress

      ENVIRONMENTAL HEALTH PERSPECTIVES
    85. Kruk, PA; Godwin, AK; Hamilton, TC; Auersperg, N
      Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer

      GYNECOLOGIC ONCOLOGY
    86. Steel, CM; Smyth, E
      Molecular pathology of breast cancer and its impact on clinical practice

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    87. Montalto, MC; Phillips, JS; Ray, FA
      Telomerase activation in human fibroblasts during escape from crisis

      JOURNAL OF CELLULAR PHYSIOLOGY
    88. Offer, H; Wolkowicz, R; Matas, D; Blumenstein, S; Livneh, Z; Rotter, V
      Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery

      FEBS LETTERS
    89. Burt, EC; McGown, G; Thorncroft, M; James, LA; Birch, JM; Varley, JM
      Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome

      BRITISH JOURNAL OF CANCER
    90. Olsen, JH; Seersholm, N; Boice, JD; Kjaer, SK; Fraumeni, JF
      Cancer risk in close relatives of women with early-onset breast cancer - apopulation-based incidence study

      BRITISH JOURNAL OF CANCER
    91. Boyle, JM; Greaves, MJ; Camplejohn, RS; Birch, JM; Roberts, SA; Varley, JM
      Radiation-induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations

      BRITISH JOURNAL OF CANCER
    92. Sevenet, N; Sheridan, E; Amram, D; Schneider, P; Handgretinger, R; Delattre, O
      Constitutional mutations of the hSNF5/INI1 gene predispose to a variety ofcancers

      AMERICAN JOURNAL OF HUMAN GENETICS
    93. Varley, JM; McGown, G; Thorncroft, M; James, LA; Margison, GP; Forster, G; Evans, DGR; Harris, M; Kelsey, AM; Birch, JM
      Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors

      AMERICAN JOURNAL OF HUMAN GENETICS
    94. HANAWALT PC
      GENOMIC INSTABILITY - ENVIRONMENTAL INVASION AND THE ENEMIES WITHIN

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    95. FINKELSTEIN SD; PRZYGODZKI R; SWALSKY PA
      MICRODISSECTION-BASED P53 GENOTYPING - CONCEPTS FOR MOLECULAR TESTING

      Molecular diagnosis
    96. DETOLEDO SM; AZZAM EI; KENG P; LAFFRENIER S; LITTLE JB
      REGULATION BY IONIZING-RADIATION OF CDC2, CYCLIN-A, CYCLIN-B, THYMIDINE KINASE, TOPOISOMERASE II-ALPHA, AND RAD51 EXPRESSION IN NORMAL HUMAN-DIPLOID FIBROBLASTS IS DEPENDENT ON P53 P21(WAF1)/

      Cell growth & differentiation
    97. Schwartz, D; Rotter, V
      p53-dependent cell cycle control: response to genotoxic stress

      SEMINARS IN CANCER BIOLOGY
    98. BAND V
      THE ROLE OF RETINOBLASTOMA AND P53 TUMOR-SUPPRESSOR PATHWAYS IN HUMANMAMMARY EPITHELIAL-CELL IMMORTALIZATION (REVIEW)

      International journal of oncology
    99. BIRCH JM; BLAIR V; KELSEY AM; EVANS DG; HARRIS M; TRICKER KJ; VARLEY JM
      CANCER PHENOTYPE CORRELATES WITH CONSTITUTIONAL TP53 GENOTYPE IN FAMILIES WITH THE LI-FRAUMENI-SYNDROME

      Oncogene
    100. BARLEY RDC; ENNS L; PATERSON MC; MIRZAYANS R
      ABERRANT P21(WAF1)-DEPENDENT GROWTH ARREST AS THE POSSIBLE MECHANISM OF ABNORMAL RESISTANCE TO ULTRAVIOLET-LIGHT CYTOTOXICITY IN LI-FRAUMENI SYNDROME FIBROBLAST STRAINS HETEROZYGOUS FOR TP53 MUTATIONS

      Oncogene


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:09:13